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ABSTRACT Clostridioides difﬁcile (Clostridium difﬁcile) sequence type 11 (ST11) is
well established in production animal populations worldwide and contributes con-
siderably to the global burden of C. difﬁcile infection (CDI) in humans. Increasing evi-
dence of shared ancestry and genetic overlap of PCR ribotype 078 (RT078), the most
common ST11 sublineage, between human and animal populations suggests that
CDI may be a zoonosis. We performed whole-genome sequencing (WGS) on a col-
lection of 207 ST11 and closely related ST258 isolates of human and veterinary/envi-
ronmental origin, comprising 16 RTs collected from Australia, Asia, Europe, and
North America. Core genome single nucleotide variant (SNV) analysis identiﬁed mul-
tiple intraspecies and interspecies clonal groups (isolates separated by 2 core ge-
nome SNVs) in all the major RT sublineages: 078, 126, 127, 033, and 288. Clonal
groups comprised isolates spread across different states, countries, and continents,
indicative of reciprocal long-range dissemination and possible zoonotic/anthro-
ponotic transmission. Antimicrobial resistance genotypes and phenotypes varied
across host species, geographic regions, and RTs and included macrolide/lincos-
amide resistance (Tn6194 [ermB]), tetracycline resistance (Tn6190 [tetM] and Tn6164
[tet44]), and ﬂuoroquinolone resistance (gyrA/B mutations), as well as numerous ami-
noglycoside resistance cassettes. The population was deﬁned by a large “open” pan-
genome (10,378 genes), a remarkably small core genome of 2,058 genes (only 19.8%
of the gene pool), and an accessory genome containing a large and diverse collec-
tion of important prophages of the Siphoviridae and Myoviridae. This study provides
novel insights into strain relatedness and genetic variability of C. difﬁcile ST11, a lin-
eage of global One Health importance.
IMPORTANCE Historically, Clostridioides difﬁcile (Clostridium difﬁcile) has been associ-
ated with life-threatening diarrhea in hospitalized patients. Increasing rates of C. dif-
ﬁcile infection (CDI) in the community suggest exposure to C. difﬁcile reservoirs out-
side the hospital, including animals, the environment, or food. C. difﬁcile sequence
type 11 (ST11) is known to infect/colonize livestock worldwide and comprises multi-
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ple ribotypes, many of which cause disease in humans, suggesting CDI may be a
zoonosis. Using high-resolution genomics, we investigated the evolution and zoo-
notic potential of ST11 and a new closely related ST258 lineage sourced from di-
verse origins. We found multiple intra- and interspecies clonal transmission events in
all ribotype sublineages. Clones were spread across multiple continents, often with-
out any health care association, indicative of zoonotic/anthroponotic long-range dis-
semination in the community. ST11 possesses a massive pan-genome and numerous
clinically important antimicrobial resistance elements and prophages, which likely
contribute to the success of this globally disseminated lineage of One Health impor-
tance.
KEYWORDS antimicrobial resistance, Clostridium difﬁcile, epidemiology, evolution,
livestock, microbial genomics, One Health, toxin, transmission, zoonosis
Clostridioides difﬁcile (Clostridium difﬁcile) is a toxin-producing antimicrobial-resistant(AMR) enteropathogen historically associated with diarrhea and pseudomembra-
nous colitis in hospitalized patients (1). In both the northern hemisphere and Australia,
community-acquired C. difﬁcile infection (CA-CDI) currently accounts for around a third
of all CDI cases, and production animals have been identiﬁed as potential sources/
reservoirs (1, 2). As shown by both conventional PCR and ﬁne-scale whole-genome
sequencing (WGS) approaches, the recovery of indistinguishable C. difﬁcile strains from
human and livestock populations indicates that CDI may be a zoonosis (2–5).
C. difﬁcile multilocus sequence type 11 (MLST 11 [here ST11]) is a diverse evolution-
ary lineage of global One Health importance (3, 6, 7). The principal ST11 strain lineage,
PCR ribotype 078 (RT078), is well established in porcine and bovine populations
throughout North America and Europe and is responsible for much of the human
CA-CDI in these regions (2, 6, 8, 9). Indeed, RT078 is now the third most frequently
isolated RT in human CDI in Europe (8, 10). RT078 has never been detected in Australian
livestock and causes only sporadic cases of CDI in human populations in Australia.
However, neonatal calves and piglets in Australia are reservoirs for a number of other
ST11 RTs, notably 126, 127, 033, and 288 (11–13), all of which have been isolated from
humans with CDI in Australia, Europe, the Middle East, and Asia (1, 2). While there has
been a focus on the genome and evolution of RT078 (4, 14–16), no such studies have
been performed on other ST11 RT sublineages.
To address this knowledge gap, we used high-resolution genomics to investigate
the genetic diversity, evolution, and zoonotic potential of a collection of 207 C. difﬁcile
ST11 strains of human clinical, veterinary, and environmental origins. These strains
originated from Australia, Asia, Europe, and North America, were collected between
1980 and 2016, and comprised 16 RTs, including major ST11 sublineages 078, 126, 127,
033, and 288 (n 196) and 11 unique RTs not previously reported in our laboratory
(Fig. 1). A detailed summary of strains and epidemiological data is provided in Data Set
S1 hosted at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare.4822255) and outlined in
Materials and Methods.
RESULTS
Of the 207 sequenced genomes, 200 (96.6%) were conﬁrmed in silico as ST11 and as
belonging to evolutionary clade 5. The remainder (n 7 [3.4%], including six RT126
strains and one QX360 strain, all Australian in origin) were assigned to a novel clade 5
lineage, ST258 (see Data Set S1 at ﬁgshare [https://doi.org/10.6084/m9.ﬁgshare
.4822255]). ST258 is a double-locus variant of ST11, differing in just 3 of 3,501 nucle-
otides (atpA, C138T and T205C; tpi, G326A) (0.09%). This ﬁnding was somewhat
unexpected as, to date, all RT126 strains have been reported as ST11. For a global
phylogenetic context, the relative evolutionary relatedness of STs 11 and 258, as well
as other prominent STs from clades 1 to 4, is shown in Fig. S1 in Data Set S1. The RT
was conﬁrmed for these strains (see Fig. S2 in Data Set S1), and given the close
evolutionary relationship to ST11, they were included in all subsequent analyses. WGS
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metrics, MLST data, and features for the 207 genomes evaluated in this study are
summarized in Data Set S1.
Intra- and interspecies transmission of globally disseminated C. difﬁcile clade
5 clones. The phylogenetic structure and clonal subpopulations of the 200 ST11 and 7
ST258 strains were explored by high-resolution core genome single nucleotide variant
(SNV) analysis. WGS reads were mapped to the ﬁnished chromosome of C. difﬁcile
RT078 strain M120 (ST11 [NC_017174]) to a median depth of 100. After ﬁltering for
indels, repetitive regions, mobile genetic elements, and putative recombination re-
gions, a total of 1,076 high-quality SNVs in the clonal frame were found across the
207-sample data set and used for maximum likelihood (ML) tree building (Fig. 2A). The
SNV-based ML phylogeny revealed 6 distinct evolutionary clusters, which were broadly
congruent with RT/ST lineage and toxin gene proﬁle: (i) a large group of 99 strains
primarily comprising RT126 and RT078 (designated the RT126/078 cluster), (ii) a group
of 33 strains comprising exclusively RT033 and RT288 (the RT033/288 cluster), (iii to v)
three distinct groups of strains (44, 3, and 21, respectively), belonging predominantly to
RT127 (RT127 clusters I to III), and (vi) a divergent group of 7 ST258 strains (the ST258
cluster). Individual phylogenies for each cluster, annotated with metadata, are pre-
sented in Data Set S1 at ﬁgshare.
In all clusters, there was a general absence of geographic grouping and signiﬁcant
overlap of clinical and nonclinical strains, a ﬁnding that supports similar RT- and
MLST-based studies that have shaped the hypothesis that strains of ST11 common to
humans, animals, and the environment share a recent evolutionary history (1, 3, 17). To
provide ultrahigh resolution of this strain population and to examine this hypothesis
further, the SNV phylogeny was investigated for signatures of clonal transmission.
Following the standard approach of Eyre et al. (4, 18, 19), a species-speciﬁc molecular
clock of 1 to 2 SNVs per genome per year was applied, with a cutoff of 0 to 2 core
genome SNVs indicative of a plausible clonal transmission event (Fig. 2B). These
thresholds have been shown to be congruent with cutoffs used for core genome MLST
(cgMLST), which is based on 2,270 loci and uses a threshold of a difference of7 alleles
to deﬁne isolates as being unrelated, whereas a difference of 6 alleles is used to
deﬁne isolates as likely to belong to the same clone (20).
FIG 1 Molecular epidemiology. PCR ribotyping banding patterns for 16 unique C. difﬁcile RTs analyzed in this study (n 207). The corresponding toxin gene
proﬁle is also provided. Origin: CLIN, clinical; VET, veterinary; ENV, environmental; RT, PCR ribotype; QX, novel RT assignment (internal nomenclature). Superscript
a indicates the molecular epidemiology for some of these strains is based on previously published works (4, 36).
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Applying the threshold of Eyre et al., 25 clonal groups (CG1 to -25) were identiﬁed
across the six phylogenetic clusters, deﬁned as groups of two or more strains differing
by 2 SNVs in their core genome (Table 1). These CGs comprised 25 distinct clones of
major RTs 078, 126, 127, 033, and 288 and encompassed 117 isolates of clinical and
nonclinical origins (Table 1). Overall, 19/25 CGs (76%) comprised strains isolated from
the same host species, indicating intraspecies clonal transmission, while the remaining
six CGs (24%) showed evidence of interspecies clonal transmission. Furthermore, many
CGs revealed long-range transmission of C. difﬁcile clones across local, national, and
international distances (Table 1).
C. difﬁcile ST11 possesses an extensive AMR repertoire. The 207 C. difﬁcile
genomes were screened in silico for acquired and intrinsic resistance determinants. Of
FIG 2 Microevolutionary analysis and clonal transmission. (A) Maximum likelihood phylogeny of 207 C. difﬁcile genomes based on evolution in 1,076
nonrecombinant, nonrepetitive core genome SNVs in clonal frame. Taxa are colored according to RT lineage: RT033/288 (green; n 33), RT078 (red; n 40),
RT126 (blue; n 69), RT127 (orange; n 54), or other (gray; n 11). Strain origin is indicated in yellow (clinical, taxa preﬁxed with “C”) and purple
(veterinary/environmental, taxa preﬁxed with “V/E”). Clonal relationships (two or more strains sharing 2 core genome SNVs) are indicated in black. The tree
is midpoint rooted, and the nodes are supported by 1,000 nonparametric bootstrap replicates (values of 95 are shown [*]). The overall topology supports PCR
ribotype assignment with six major strain clusters identiﬁed (the RT126/078 cluster, RT127 clusters I to III, the RT033/288 cluster, and the sequence type 258
[ST258] cluster). (B) Distribution plots showing core genome SNV distances between each strain and the genetically closest strain in each cluster. Vertical lines
represent the 2-SNV cutoff for the identiﬁcation of clonally transmitted strains (18). In “RT127*,” the asterisk indicates that clusters I to III are merged.
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TABLE 1 Summary of intra- and interspecies clonal groupsa
CG Clone n Transmission C. difﬁcile source Range Yr Comments
1 RT078 3 Intraspecies CDI International
and national
2010–2012 3 HCFs in Rotterdam,
Netherlands,
and in Australia
(WA and NSW)
2 RT078 2 Interspecies Piglet feces and
asymptomatic
farm worker
Local 2011 1 farm in Heino, Netherlands;
corroborates work of
Knetsch et al. (4)
3 RT126 6 Intraspecies CDI International
and national
2007–2013 3 HCFs in Australia
(NSW, WA, and VIC) and
1 HCF in Tainan, Taiwan
4 RT126 12 Intraspecies CDI International
and national
2006–2013 3 HCFs in Toscana
region of Italy,
1 HCF in Illinois,
and 3 HCFs in 2
Australian states
(WA and NSW)
5 RT126 2 Intraspecies CDI Local 2012 1 HCF in NSW, Australia
6 RT126 2 Intraspecies CDI Local 2006 1 HCF in NSW, Australia
7 RT126 2 Intraspecies CDI (both CA-CDI) Local 2011 2 distinct HCFs in NSW
and VIC, Australia
8b RT078 2 QCc
9 RT078 2 Intraspecies CDI (1 CA-CDI) National 2013–2016 2 distinct HCFs in
WA and NSW,
Australia
10 RT078 2 Intraspecies CDI National Unknown 1 HCF in Illinois
11 RT126 7 Interspecies CDI, calf feces and
calf carcass washing
National 2012–2013 3 distinct farms in 2 Australian
states (VIC and QLD) and
1 HCF in NSW, Australia
12 RT127 24 Interspecies CDI (one CA-CDI),
calf feces and
calf carcass washing
National 2011–2014 5 distinct farms in 2 Australian
states (VIC and NSW) and
5 distinct HCFs in 2
Australian states (NSW and WA)
13 RT127 4 Intraspecies CDI (1 pediatric) National 2006–2008 3 distinct HCFs in Australia
(NSW and WA)
14 RT127 3 Interspecies CDI, calf feces National 2011–2012 1 HCF in NSW, Australia,
and 1 farm in QLD, Australia
15 RT127 2 Intraspecies CDI (both CA-CDI) Local 2006 1 HCF in VIC, Australia
16 RT127 6 Intraspecies CDI Local 2010 1 HCF (ward) in Tokyo, Japan
17 RT127 2 Intraspecies CDI Local 2011–2012 1 HCF in Tainan, Taiwan
18 RT127 4 Intraspecies CDI Local 2005–2006 3 distinct HCFs in WA, Australia
19 RT126b 5 Interspecies CDI (1 pediatric,
1 CA-CDI) and
kangaroo feces
Local 2009–2012 3 distinct HCFs and 1
veterinary hospital, all in
WA, Australia (26)
20 RT033 3 Intraspecies CDI Local 2006 1 HCF in VIC, Australia
21 RT033 2 Intraspecies CDI Local 1980–1982 1 HCF in VIC, Australia
22 RT033/288 6 Interspecies CDI (1 pediatric),
calf feces, and
calf carcass washing
National 2012–2013 4 distinct farms in 3 Australian
states (NSW, VIC, and QLD) and
2 HCFs in WA/VIC, Australiae
23 RT033 6 Intraspeciesd Piglet feces, soil
irrigated with
efﬂuent, and
treated liquid
efﬂuent
Local 2012–2015 2 farms in SA, Australia
24 RT033 6 Intraspecies CDI National 2011–2013 6 CDI epidemiologically
unrelated cases from 6 distinct
hospitals in the northern,
central, and southern regions
of France, previously described
by Eckert et al. (25)
25 RT288 2 Intraspecies Calf carcass washing Local 2013 1 farm in SA, Australia
aCG, clonal group; RT, PCR ribotype; CDI, Clostridium difﬁcile infection; CA-CDI, community-associated CDI; HCF, health care facility; SA, South Australia; QLD;
Queensland; NSW, New South Wales; VIC, Victoria; WA, Western Australia; QC, quality control.
bST258.
cM120 (accession no. NC_017174) was used as a reference chromosome for read mapping and SNV calling. For quality control purposes, the original paired-end reads
for this strain (accession no. ERR027342) were obtained from the study by He et al. (41) and processed and analyzed as an additional test genome. SNV analysis
correctly showed C137 and M120 to be indistinguishable (zero core genome SNV differences).
dTransmission between piglets (feces) and environment (soil/efﬂuent).
eNotably, one strain is RT288, and the remainder are RT033.
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these strains, 185 were available for in vitro phenotypic testing. Summary MIC distri-
butions for 13 antimicrobial agents, by RT lineage, are presented in Fig. 3A, and the MIC
range, MIC50, MIC90, and geometric mean (GM) for all RT lineages are presented in Data
Set S1 at ﬁgshare. All strains including ST258 were fully susceptible to vancomycin,
metronidazole, ﬁdaxomicin, rifaximin, amoxicillin-clavulanate, trimethoprim, and
piperacillin-tazobactam (Fig. 3A; see Data Set S1 at ﬁgshare).
Overall, 48.1% of strains showed phenotypic resistance to one or more of the agents
tetracycline, moxiﬂoxacin, erythromycin, and clindamycin, 25.4% of which (predomi-
nantly RT126/078), were multidrug resistant (MDR): i.e., resistant to 3 of these agents.
Resistance was conferred by a diverse selection of acquired AMR genes (479 individual
genes of 22 types across 4 antimicrobial classes) and intrinsic mutations in DNA gyrase
subunit genes (Fig. 4A; see Data Set S1 at ﬁgshare). The distribution of AMR genotypes
and the key genetic features of major AMR-encoding transposons found in this
population are presented in Fig. 4A and Table 2, respectively.
(i) Tetracycline resistance. Nonsusceptibility to tetracycline was seen in 43.7%
(n 81/185 [Fig. 3B]) of strains and varied widely with RT lineage (RT126, 77.6%; RT078,
70.0%; other, 54.5%; RT127, 14.9%; and RT033/288, 3.0%; P  0.0001 [see Data Set S1
at ﬁgshare]). All ST258 strains were susceptible to tetracycline. One or more tetracycline
resistance genes (tetM, tet-40, tetO, and tet-44) were identiﬁed in 47.8% (n 99/207) of
sequenced genomes, and the tetracycline genotype showed concordance with the
tetracycline phenotype in all 185 strains tested (Fig. 3B and 4A; see Data Set S1 at
ﬁgshare). All tetM-positive strains harbored Tn6190, a conjugative element closely
related to Tn916 from Enterococcus faecalis (Table 2). For tet-40, no discernible trans-
posons were identiﬁed; however, all 75 tet-40 genes in this population were conserved
and shared 100% sequence identity (seqID) and ﬂanking regions with tet-40 sequences
from the rumen species Megasphaera elsdenii (CP009240) and Streptococcus suis
(KC790465.1). The single tet-O gene found in an RT078 strain shared 100% and 99%
seqID with tet-O from Campylobacter jejuni and S. suis (CP012911.1). Six RT078 strains
carried tet-44 on a conjugative transposon, Tn6164 (Table 2).
(ii) Fluoroquinolone resistance. Nonsusceptibility to moxiﬂoxacin was 25.9%
(n 48/185 [Fig. 3B]) and varied widely with RT lineage (RT126, 49.3%; RT078, 40.0%;
other, 27.0%; RT127, 5.6%; and RT033/288, 3.0%; P  0.0001 [see Data Set S1 at
ﬁgshare]). All ST258 strains were susceptible to moxiﬂoxacin. Full-length sequences for
gyrA/B were characterized for polymorphisms within their quinolone resistance-
determining regions (QRDRs) using the scheme of Dingle et al. (21). Two alleles were
identiﬁed for gyrA (gyrA-2 and -31) and four for gyrB (gyrB-12, -39, -93, and -96). Of these,
gyrA-31 and gyrB-39, -93, and -96 had mutations leading to nonsynonymous amino acid
changes within the gyrA/gyrB QRDRs resulting in ﬂuoroquinolone resistance (FQR; 100%
phenotype-genotype concordance [Fig. 3B and 4A]).
(iii) MLSB resistance. Overall nonsusceptibility to clindamycin and/or erythromycin
was 38.9% (n 72/185 [Fig. 3B]). Nonsusceptibility to these agents varied widely with
RT lineage (clindamycin, RT078, 55.0%; RT126, 31.3%; other, 27.3%; RT033/288, 15.2%;
and RT127, 5.6%; P  0.0001; erythromycin, RT126, 70.2%; RT078, 60.0%; other, 18.0%;
RT033/288, 11.3%; and RT127, 7.0%; P  0.0001 [see Data Set S1 at ﬁgshare]). All ST258
strains were susceptible to clindamycin and/or erythromycin. The 23S rRNA methyl-
transferase gene, ermB, was found in 13.0% of strains (n 27/207 [Fig. 4A; Data Set S1]).
All ermB strains were negative for Tn6215, Tn6218, and the most common ermB-
carrying element in this species, Tn5398 (1). Of the 27 ermB strains, 77.8% (n 21)
harbored conjugative transposon Tn6194 (HG475346.1). Of the six remaining strains,
four showed signiﬁcant homology (99% seqID) to a 12-kbp AMR gene cluster from
Campylobacter coli (KT953380.1). Overall, in silico AMR genotyping was a poor predictor
of AMR phenotype, with only 36.1% of MLSB (macrolide-lincosamide-streptagramin
B-positive) isolates harboring ermB (Fig. 3B). The remainder were also negative for ermA
and ermC, ribosomal proteins (L4/L22), and 23S rRNA gene mutations, suggesting an
alternative AMR mechanism (data not shown).
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FIG 3 In vitro antimicrobial susceptibility. (A) MIC distributions for 13 antimicrobial agents against 185 C. difﬁcile. VAN, vancomycin; MTZ,
metronidazole; FDX, ﬁdaxomicin; RFX, rifaximin; AMC, amoxicillin-clavulanate; CLI, clindamycin; ERY, erythromycin; CRO, ceftriaxone; MEM,
(Continued on next page)
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(iv) Aminoglycoside resistance. One or more aminoglycoside/streptothricin resis-
tance genes were found in 45.4% (n 94) of isolates (Fig. 4A; see Data Set S1 at
ﬁgshare). The aph3-III–sat4A–ant6-Ia cassette was present in 39.6% (n 82) of isolates
(Fig. 4A) and shared 99% seqID to a 7,269-bp fragment of an MDR cassette from
Erysipelothrix rhusiopathiae (KP339868.1). The genetic context for ant6-Ib and ant9-Ia
(present only in six strains of RT078) was Tn6164, the same 106-kb genetic island
harboring tet-44 (14) (Fig. 4A and Table 2).
(v) Other resistance loci. All isolates contained the -lactamase-inducing penicillin-
binding protein gene blaR (CD630_04700), the efﬂux resistance gene cme
(CD630_31980), and in a single isolate, the lincomycin resistance gene lnuC
(AY928180.1). No rpoB mutations were detected, corroborating the rifaximin pheno-
type. Also, none of the 207 ST11/258 genomes harbored a vanGCD operon (1).
However, as we have previously described (22), a single RT033 strain isolated from an
Australian veal calf at slaughter harbored syntenic vancomycin resistance genes vanXB,
vanB, vanHB, vanW, vanYB, vanSB, and vanRB (Fig. 4A and Table 2), but did not show any
reduced susceptibility to vancomycin in vitro (MIC, 1 mg/liter), possibly a result of an
aberrant vanRB operon. This “vanB2-like” operon was carried on an 42-kb Tn1549, a
conjugative transposon linked with the emergence and global dissemination of
vancomycin-resistant enterococci, the ﬁrst such ﬁnding in C. difﬁcile (22).
FIG 3 Legend (Continued)
meropenem; MXF, moxiﬂoxacin; TET, tetracycline; TZP, piperacillin-tazobactam; TMP, trimethoprim. Where available, established susceptible and
resistant breakpoints are indicated by vertical green and red lines, respectively. (B) Plots showing overall percentage of nonsusceptibility and
percentage of phenotypic-genotypic concordance for the TetR (tetracycline-resistant), FQR (ﬂuoroquinolone-resistant), and MLSB (macrolide-
lincosamide-streptogramin B-resistant) phenotypes.
FIG 4 Comparative analysis of antimicrobial resistance (AMR) and virulence loci. Shown are heat maps visualizing the distribution of AMR (A) and
virulence/pathogenicity (B) loci across the 207-genome data set. Presence is indicated by black bars and absence by light blue bars. Strains are arranged from
left to right according to RT lineage: RT033/288 (green; n 33), RT078 (red; n 40), RT126 (blue; n 69), RT127 (orange; n 54), and other (gray; n 11). Strain
origin is also indicated in yellow (clinical) and purple (veterinary/environmental). Superscript a indicates results comprising syntenic vanXB, vanB, vanHB, vanW,
vanYB, vanSB, and vanRB genes. Superscript b indicates the combination of QRDR mutations in gyrA (Thr82Ile) and gyrB (Ser366Val, Ser416la, Asp426Asn, and
Glu466Val). Superscript c indicates results are according to the scheme of Dingle et al. (21). (Alleles 20 and 21 are novel and were identiﬁed in this study.)
Superscript d indicates results are according to the scheme of Curry et al. (23) (characterized by C¡T substitution at nucleotide 184 and an in-frame deletion
of 39 bp at nucleotide positions 341 to 379). Superscript e indicates the wild-type (WT) 747-bp cdtR allele. Superscript f indicates the variant (VNT) 324-bp cdtR
allele. Superscript g indicates results are according to the scheme of Dingle et al. (21) (characterized by diversity in slpA, cwp66, cd2790, cwp2, and secA2).
(Cassette type DK1 is novel and was identiﬁed in this study but has yet to be assigned an ofﬁcial number by the curators of the Bacterial Isolate Genome
Sequence Database.)
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Clade 5 sublineages show signiﬁcant diversity in key virulence loci. In silico
genotyping conﬁrmed that the pathogenicity locus (PaLoc) genes tcdA, tcdB, tcdE, and
tcdR were present in all large clostridial toxin (LCT) RT lineages, but absent from LCT
RTs 033 and 288 (Fig. 4B). The tcdC gene was conserved across all strains and contained
genetic changes that result in an aberrant, signiﬁcantly truncated TcdC: a C¡T substi-
tution at nucleotide 184 and an in-frame deletion of 39 bp at nucleotides 341 to 379
(23).
TABLE 2Major AMR-encoding transposonsa
Tn
(accession
no.)
AMR locus
and mechanism Key genetic features and architecture Reference
Tn6194
(HG475346)b
ermB: methylation
of 23S rRNA of
bacterial 50S
ribosomal subunit,
thereby reducing
binding afﬁnity of
MLSB class
antimicrobials
28,014 bp in size and 35 CDSs 44
1 copy of ermB, distinguishing it from Tn5398, which has 2 copiesc
Recombination module comprising int (1,446 bp) and xis (258 bp) genes
int/xis genes invariably found adjacent to a tRNA gene (Arg)
Contains toxin ( [159 bp]), antitoxin ( [273 bp]), and 3= cell
surface protein (3,045 bp) genes
Tn6190
(FN665653)
tetM: mimics ribosomal
elongation factors,
protecting against
antitranslational activity
of tetracyclines
18,032 bp in sized 41
Contains a recombination module comprising int (1,218 bp) and
xis (204 bp) genes, distinguishing it from Tn5397, which contains
a site-speciﬁc recombinase gene, tndXe
orf12 (encoding a leader peptide) is absent and lacks the 1,831-bp
group II intron in orf14, both characteristic features of Tn5397
Tn6164
(FN665653)f
tet-44: mimics ribosomal
elongation factors,
protecting them
from antitranslational activity
of tetracyclines
106,711 bp, containing 5 distinct modules (A to E) and 90 ORFs
originating from diverse bacterial genera (average GC content of 34%)
14
Module A (7.3 kb), located at the 5= end of the element, contains
a restriction-modiﬁcation system.
Module B (39.5 kb) contains a complete prophage of
Thermoanaerobacter sp. strain 513X (CP002210).
Module C (4.5 kb) contains part of plasmid originating from
E. faecalis (pEF418 [AF408195.1]) including spectinomycin
adenyltransferase gene ant9-Ia.
Module D (4.5 kb) is located entirely within module E, shows
homology to a pathogenicity island of Campylobacter fetus, and
harbors tet-44 and ant6-Ib genes.
Module E (51 kb) is located at the 3= end of the element and
homologous to an entire conjugative transposon from
Streptococcus pneumoniae, Tn1806.
Tn1549
(KU558763)
vanB2 operon (vanXB, vanB,
vanHB, vanW, vanYB, vanSB,
and vanRB): biosynthesis of
modiﬁed peptidoglycan precursors
(e.g., D-Ala-D-Lac or D-Ala-D-Ser)
to which vancomycin shows
reduced binding
42,375 bp in size and 38 ORFs with homology and synteny with
Tn1549 (AF129329)g
22
Recombination module comprising int (1,194 bp) and xis (201 bp) genes
The central AMR domain comprises the vanB2 operon with syntenic
vanXB, vanB, vanHB, vanW, vanYB, vanSB, and vanRB genes.
However, the vanRB genes (encoding a cytoplasmic response
regulator) are interrupted by loci from Bacillus megaterium (Bm3R1 [582 bp])
and Bacillus cereus (orf7 [1,032 bp]), respectively.
The aberrant vanRB genes are likely responsible for the cryptic
phenotype observed (22).
Deﬁning the left (L) and right (R) terminal ends of the element
were 11-bp inverted repeats matching those found in Tn1549 and
likely representing excision/integration sites.
aTn, transposon; MLSB, macrolide-lincosamide-streptogramin B; int, integrase; xis, excisionase. ORF, open reading frame.
bPreviously termed CTnCD3a (41).
cTn5398, the predominant ermB-containing element in C. difﬁcile (40).
dSize based on reported homology to Tn916 (14).
eTn5397, the predominant tetM-containing element in C. difﬁcile (40).
fPosition in C. difﬁcile M120 genome (418525 to 525236).
gTn1549, conjugative transposon linked with the emergence and global dissemination of vancomycin-resistant enterococci (22).
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Genetic diversity in the C-terminus receptor binding domain (RBD) of tcdB was
found with 70.6% of tcdB isolates (n 144/174) harboring tcdB RBD allele type 1 (21)
and the remainder carrying novel allele types 20 and 21, the latter exclusive to ST258
(Fig. 4B). These novel alleles share a recent evolutionary history with type 1 (Fig. 5B) and
contain nonsynonymous substitutions that alter the amino acid sequence and bio-
chemistry (Fig. 5C).
All strains harbored wild-type cdtA/B genes, but two variants of cdtR were identiﬁed:
(i) a 324-bp cdtR allele was found exclusively in RTs 078/126, which, due to a stop codon
at position 322, results in a truncated CdtR (from 248 to 108 amino acids [aa]) and (ii)
a wild-type 747-bp cdtR allele was found only in non-078/126 strains (see Data Set S1
at ﬁgshare). Finally, characterized by diversity in slpA, cwp66, cd2790, cwp2, and secA2
(21), 4 distinct S-layer cassettes were identiﬁed (including one novel type) that were
broadly congruent with the RT and/or ST lineage (Fig. 4B).
Clade 5 possesses a massive open pan-genome and a diverse population of
temperate prophages. To quantify the entire genomic repertoire of the strain popu-
lation, estimates of the pan-genome, core genome, and accessory genome were
generated. The pan-genome was vast, comprising 10,378 genes, while the core and
accessory genomes were 2,058 and 8,320 genes, respectively (Fig. 6A). The pan-
genome showed characteristics of an “open” pan-genome (24). First, the pan-genome
FIG 5 tcdB receptor binding domain (RBD) diversity. (A) Organization of the four functional domains of the 2,366-
amino-acid TcdB protein. The 597-bp variable region within the C-terminus receptor binding domain (RBD) is indicated
(horizontal red bar). The ﬁgure was adapted from Dingle et al. (21). (B) Neighbor-joining phylogeny for 21 currently
described tcdB RBD alleles. Tips are colored according to the MLST clade (see the color key). Novel alleles identiﬁed in
this study (open green circles) are clustered with known MLST clade 5 allele type 1 (reported to date in the RT078 and
RT126 lineages). Each sequence is 198 amino acid residues in length. Sequences were aligned using MUSCLE, and the
tree was generated in MEGA6 with evolutionary distances calculated using the Tajima-Nei model. The scale bar shows
the number of amino acid substitutions per site. The tree is midpoint rooted and supported by 500 bootstrap replicates.
(C) Summary of nucleotide and amino acid changes in novel tcdB RBD variants.
Knight et al. ®
March/April 2019 Volume 10 Issue 2 e00446-19 mbio.asm.org 10
 o
n
 June 23, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
increased in size unboundedly with sampling of new genomes. At n 207, the pan-
genome exceeded more than double the average number of genes found in a single
ST11/258 genome (3,640) and the plot was yet to reach a plateau, indicating more
sequenced strains are needed to capture the complete gene complement. Second, the
number of new genes did not converge to zero upon sequencing of new strains (at
n 207, an average of 16 new genes were contributed to the gene pool [Fig. 6A]).
Finally, curve analysis using a power law regression model (24) showed the pan-
genome was open (Bpan  0.46 [Fig. 6A]). The core genome curve depicts a trend of
core genome size contraction with progressive addition of sequential genomes
(Fig. 6B), ultimately converging at 2,058 genes at n 207. Notably, the core genome
accounted for just 19.8% of the total gene repertoire and 56.5% of an average ST11/258
genome (range, 49.8 to 60.2).
A total of 221 intact, 73 questionable, and 478 incomplete prophages were identi-
ﬁed in the study population. A summary of the distribution and genetic features of
intact prophages is shown in Fig. 6C and Data Set S1 (at ﬁgshare), respectively. The
intact prophages comprised 14 “phage types,” ranging between 14.3 and 184.6 kb in
length, with an average GC content of 29.9%, comparable to the average GC content
FIG 6 Pan-genome and prophage content. The total numbers of genes in the pan-genome (A) and core genome (B) are plotted as a function of the number
of genomes sequentially added (n 207). (A) The pan-genome size is calculated at 10,378 genes at n 207 and displays characteristics of an open genome:
(i) the trajectory of the pan-genome increases unboundedly as the number of genomes are added, and (ii) Bpan (	 [55]) was estimated as 0.46 (curve ﬁt,
r2  0.999). Box plots indicate the 25th and 75th percentiles, with medians shown as horizontal lines and whiskers set at the 10th and 90th percentiles. (B)
Consistent with an open pan-genome, the core genome curve (r2  0.985) converges to 2,058 genes at n 207, where an average of 16 new strain-speciﬁc
genes are contributed to the gene pool. Overall, the core genome accounts for just 19.8% of the total gene repertoire. (C) Summary of intact prophage content
found in 207 C. difﬁcile strains of ST11 and ST258. More prophages were found in LCT RTs versus LCT RTs, the RT127 lineage versus the RT126 and -078
lineages, and veterinary versus clinical strains (P  0.001).
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for the C. difﬁcile host (28.7%). The most common prophage was MMP03 (n 57),
followed by CD506 (n 45), CDHM19 (n 41), CDMH1 (n 25), CD27 (n 17),
MMP02 (n 12), and MMP01 (n 7) (Fig. 6C; see Data Set S1).
DISCUSSION
C. difﬁcile RT078 is a prominent ST11 sublineage that has established signiﬁcant
reservoirs in production animals worldwide (1, 2). It has also been recovered from
various retail meat products in North America and Europe (2) and is a major cause of
hospital-acquired (HA)- and CA-CDI in those regions (6, 8, 9). In many countries,
although often to a lesser extent, ST11 RTs 126, 127, 033, and 288 have been recovered
from humans with CDI (8, 10, 25–31), as well as livestock, slaughterhouses, and retail
meat products (11–13, 30, 32–35).
Using large-scale high-resolution WGS, we provide novel insights into the evolution
and genetic repertoire of ST11 and its close relative ST258. The global population
structure largely mirrored the RT sublineage, with 6 discrete evolutionary clusters
comprising highly genetically related strains unconstrained by geographic, temporal, or
host species origin. Core genome analysis revealed intra- and interspecies clonal
transmission of C. difﬁcile in all the major ST11 sublineages and within the closely
related novel clade 5 lineage ST258, which is potentially associated with CA-CDI and
patients with hematological/oncological malignancies (26). Clones were spread across
geographically distinct health care facilities and farms and indicated reciprocal long-
range dissemination and possible zoonotic/anthroponotic transmission locally, nation-
ally, and internationally. Our work supports and extends the ﬁndings of Knetsch and
colleagues, who, not surprisingly, showed transmission of RT078 between a pig and pig
farmer within the conﬁnes of a pig-rearing facility (4). In reconstructing the global
RT078 population structure, they later revealed an intercontinental transmission net-
work between humans and production animals of RT078 (15).
Our analysis also provided some interesting insights into the overall evolution of
ST11/258. First, RTs 126 and 078 did not cluster into distinct subpopulations, suggesting
they have coevolved, at least over their core genome, as a single heterogeneous
lineage, a ﬁnding that supports their frequent reporting as a single RT group (1, 36). A
similar observation was made for the LCT RTs 033 and 288, but the position of
RT078/126 at the base of the phylogeny suggests they may be the more ancient of the
clade 5 sublineages. Taken together, these phylogenetic analyses reveal a globally
disseminated network of clones with the capability and proclivity for reciprocal clonal
transmission between production animals and humans with CDI. Moreover, these
ﬁndings challenge the existing paradigm and long-held conception that CDI is primarily
a health-care-associated infection and provide compelling evidence that CDI is a
zoonosis. While some human infections in Australia are likely a result of international
travel (e.g., clones of RT078), our analyses also indicate a persistent community reser-
voir with extensive long-range domestic dissemination. Due to the high prevalence of
C. difﬁcile in neonatal cattle and pigs, the consumption of contaminated retail meats is
a conceivable mechanism for transmission (2, 11). However, evidence from studying
RT014, the most common RT found in humans and pigs in Australia, suggests a
zoonotic transmission chain extending from the farrowing shed to the community (5,
12, 37). C. difﬁcile can be found in 67% of Australian piglets (12), on 20% of retail root
vegetables grown in soil containing animal feces (38), in 59% of public lawns in Western
Australia (39), and in 30% of retail compost and manure (unpublished data), with RT014
comprising between 7 and 67% of isolates in these settings. In a manner analogous to
human infection, excessive exposure to antimicrobials, particularly to cephalosporins, is
driving the expansion of C. difﬁcile in livestock populations worldwide and resulting in
spillover of C. difﬁcile into the environment and CDI in the community (37).
AMR can evolve rapidly in C. difﬁcile and is a key factor driving genetic diversity and
epidemiological changes in CDI (1). The ST11 lineage has a substantial AMR repertoire,
characterized by high levels of phenotypic resistance to tetracycline, moxiﬂoxacin,
clindamycin, or erythromycin, predominantly within the RT 126/078 lineages.
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TetR strains of C. difﬁcile comprise up to 41% of European clinical isolates (40). We
found 30% of ST11 isolates had a TetR phenotype conferred by efﬂux and ribosomal
protective proteins, expressed by Tn6190 (tetM) and Tn6164 (tet-44). Tn6190 has a
strong afﬁliation with the RT126/078 lineages, present in 79.7% and 55.0% of strains in
this study, respectively, and to date only reported in these RTs (14, 16, 41). Similarly,
Tn6164 has been found in RT078 only and, prior to this study, only within Europe.
Corver et al. (14) suggest there may be an association between the presence of this
genetic island and enhanced virulence in RT078 strains: CDI-associated mortality was
more common in patients infected with C. difﬁcile strains harboring Tn6164 (29% versus
3%) (14). The association of these elements with RTs 078 and 126 could provide a
ﬁtness advantage, other than AMR, and be a contributing factor in their success
compared to the less widespread LCT and RT127 lineages. Indeed, a recent study by
Dingle et al. (57) provides compelling evidence that tetracycline selection played a
crucial role in the rapid and recent international spread of RT078 clones.
The prevalence of FQR in European C. difﬁcile populations can be as high as 40%,
mainly associated with hospital outbreaks of RT027 strains (10, 42, 43). As with RT027,
FQR might also be an important driver of clonal expansion in ST11. In our study, FQR
was largely restricted to RT078/126 strains of human clinical origin and was notably
absent in C. difﬁcile from Australian livestock, reﬂecting the current restrictions on
ﬂuoroquinolone usage in food animals in this country (10).
WGS permits rapid prediction of an antimicrobial phenotype. We found concor-
dance between MICs and in silico AMR screening was high for the tetracycline and
ﬂuoroquinolone phenotype (100%), but poor for the MLSB phenotype (36.1%). Over a
third of all strains, again principally RTs 126/078, had an MLSB phenotype, yet only 36%
of these harbored ermB Tn6194, the ﬁrst such report from humans in Australia or from
animals elsewhere in the world. This element is the most common ermB-containing
element in European human clinical isolates, has interspecies transfer proﬁciency, and
is one of the deﬁning genetic features of epidemic RT027 (1, 40, 42). The explanation
for the MLSB ermB mutant is not clear. Such strains did not contain alterations in
ribosomal proteins or 23S rRNA, both alternative mechanisms from which reduced
susceptibility to macrolides and lincosamides can arise (43). Previously, Spigaglia et al.
(43) showed that treatment of MLSB ermB mutant strains with two efﬂux pump
inhibitors did not lead to reductions in MICs. Therefore, it appears that in the ST11
lineage ermB is not the primary mechanism underlying the MLSB phenotype, and other
mechanisms, potentially efﬂux but possibly novel, may be at play.
Many of the underlying AMR elements we identiﬁed show provenance in different
commensal species residing within the gut of pigs and cows. Some of these elements
are fully capable of both intraspecies transfer to different C. difﬁcile RTs and interspecies
transfer to other genera (41, 42, 44). Taken together with our microevolutionary
analysis, this suggests that ST11 and perhaps also ST258 has the capability and
propensity to move between production animals and humans and in doing so can
possibly access and exchange DNA with an enormously diverse metagenome found in
the human and pig (monogastric) and cow (ruminant) gut microbiota. The high
prevalence of cryptic aminoglycoside and streptothricin resistance gene clusters orig-
inating from E. rhusiopathiae is intriguing as C. difﬁcile is inherently resistant to
aminoglycosides. It most likely reﬂects a long history of reciprocal lateral gene transfer
within the monogastric and ruminant gut environments, with C. difﬁcile likely serving
as a reservoir of AMR loci, for both other C. difﬁcile lineages and other commensal
genera.
Analysis of genes common to the PaLoc, CdtLoc, and S-layer identiﬁed several new
alleles and many instances of RT/ST lineage-speciﬁc diversity. These ﬁndings may
indicate evolution within different host environments and possibly explain differences
in virulence potential between more (078 and 126) and less (033, 288, and 127)
successful lineages. For example, CDT strains are associated with more severe diar-
rhea, a higher case-fatality rate, and refractory disease (45). The high sequence diversity
in cdtB (encoding the binding component of CDT), particularly between the LCT CDT
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and LCT CDT lineages, may reﬂect differences in host cell binding in vivo for these
different genotypes. Furthermore, DNA binding for the response regulator CdtR is
predicted to occur within the C-terminal domain (45). It is possible that the truncated
CdtR found exclusively in RTs 078 and 126 may be nonfunctional as a positive regulator
of cdtA/B, conferring a ﬁtness advantage in these more virulent/successful lineages.
Similarly, one of the novel tcdB RBD variants identiﬁed in this study (allele 21) was
unique to ST258. The RBD of TcdB is a critical region for interaction with host epithelial
cell membranes, and variations within this region have been associated with enhanced
virulence (1, 21). The signiﬁcant changes in amino acid biochemistry in this region
could result in an alternate, potentially less virulent (less successful), disease phenotype
compared to the more globally disseminated ST11. Finally, the S-layer plays a central
role in adaption to life in the gastrointestinal tract and evolves in response to host
immunological selection (21). The four distinct S-layer cassettes identiﬁed were highly
congruent with the RT and/or ST lineage, possibly reﬂecting evolution in different
(original) host species. Moreover, S-layer cassette typing could be a useful additional
discriminatory typing tool for the numerous RTs within ST11 and clade 5.
Comprising just 19.8% (2,058 genes) of its genetic repertoire, the core genome of C.
difﬁcile ST11/258 is remarkably small, a ﬁnding that supports earlier studies describing
ultralow genome conservation in this species (16 to 40%) (1). These values are consid-
erably lower than those for other pathogens known to have signiﬁcant genomic
variability: e.g., Helicobacter pylori (59%), Campylobacter jejuni (53%), Streptococcus
pneumoniae (47%), Escherichia coli (40%), and Legionella pneumophila (33%) (1).
At almost 10,400 genes, the pan-genome is comparable with that of Salmonella enterica
(10,000 genes), one of the most diverse species in the bacterial kingdom (46). Under-
lying the incredible diversity seen in the accessory genome is a substantial population
of Siphoviridae and Myoviridae, including C2, CD38-2, CD27, MMP02, CDHM1,
MMP03, CD506, and CDHM19. These temperate tailed prophages share a similar GC
to their host (28 to 30%) and have coevolved with C. difﬁcile over very long periods (1).
Studies have shown that in their lysogenic form, these phages are able to inﬂuence the
expression of multiple genes associated with the ﬁtness and virulence of the host
bacterium during infection, including modulation of quorum-sensing, ﬂagellar assem-
bly, AMR transduction, and toxin production (1, 47).
There are limitations to this work. While widely recognized as the current standard
approach for studies of pathogen transmission (18, 19, 48, 49), the molecular clock for
any species is an approximation based on within-host variation and the assumption of
a constant rate of evolution. Therefore, it does not account for the genetically quiescent
nature of C. difﬁcile spores and may underestimate the evolutionary distance between
strains (19). Also, with comparable resolution to SNV analysis and the added bonus of
standardized nomenclature, cgMLST could be used as a comparator typing tool in
future studies (20). Last, we acknowledge that plasmids were not investigated. Differ-
entiation of large plasmids and some prophage elements is difﬁcult, but future studies
that screen large cryptic plasmids such as pDLL3026 may provide further insights into
the evolution of clade 5 strains and their prophages.
In summary, the One Health paradigm, connecting the health of humans to the
health of animals and their shared environments, represents the optimal approach for
understanding the epidemiology and evolution of C. difﬁcile, as well as improving
strategies to curtail the growing public health threat posed by CDI. Better communi-
cation and coordinated efforts between public health authorities, veterinary medicine,
and agriculture will be key in developing interventions aimed at reducing the levels of
C. difﬁcile spores in the environment. These include curtailing the use of late-generation
cephalosporins, immunization, environmental cleaning (e.g., sporicidal treatment of
efﬂuent) and discontinuing the practice of slaughtering neonatal calves (37, 50).
Our study demonstrates the zoonotic potential of ST11 and its close relative ST258
and provides a framework for future epidemiological and experimental studies of other
livestock- or agricultural-associated lineages of C. difﬁcile. Moreover, our ﬁndings
challenge the long-held misconception that CDI is primarily nosocomial in origin and
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clearly emphasize the need for continued genetic and phenotypic surveillance of C.
difﬁcile from different ecological niches. As we have shown here, WGS provides the
ultraﬁne-scale resolution needed to decipher cryptic CDI transmission pathways and
identify emerging clones, as well as changes in AMR and key virulence loci.
MATERIALS AND METHODS
Bacterial isolates. A detailed summary of isolates (n 185), genomes (n 207), and associated
epidemiological data is provided in Data Set S1 at ﬁgshare (https://doi.org/10.6084/m9.ﬁgshare
.4822255). Brieﬂy, strains of human clinical origin (n 150) were sourced from patients with CDI in 62
unique health care facilities/hospitals in Australia (n 92), Europe (n 36), Asia (n 14), North America
(n 7), and New Zealand (n 1) and collected between 1980 and 2016. C. difﬁcile strains of veterinary
and environmental origin (n 57) were sourced from 16 unique farms, abattoirs, veterinary laboratories,
and one organic market in Australia (n 43) and Europe (n 14) between 2007 and 2015. C. difﬁcile
strains were selected based on their RT belonging to ST11 (e.g., RTs 033, 078, 126 and 127, and 288), as
well as several novel ST11 RTs (preﬁxed with “QX”). RT and toxin gene proﬁles for all 185 available C.
difﬁcile isolates were reconﬁrmed by PCR assays as previously described (13) (Fig. 1).
Whole-genome shotgun sequencing. Genomic DNA was extracted from a 48-h blood agar sub-
culture of C. difﬁcile using a QuickGene DNA tissue kit (Kurabo Industries, Osaka, Japan). A total of 185
strains were subjected to WGS using the MiSeq and HiSeq platforms and standard Nextera XT libraries
(Illumina, San Diego, CA) (5). For comparative analysis, the genomes of 22 previously sequenced human
clinical ST11 strains from European studies (4, 36, 41) were also included in this study. Accession numbers
for WGS data are provided in Data Set S1 at ﬁgshare.
Microevolutionary analysis. Core genome single nucleotide variant (SNV) analysis followed the
“gold standard” approach of Eyre et al. (18), as recently described (5). Brieﬂy, trimmed reads were
mapped to the ﬁnished chromosome of C. difﬁcile strain M120 (ST11 [accession no. NC_017174]) using
Smalt v0.7.6 (www.sanger.ac.uk/resources/software/smalt/). Candidate SNVs were ﬁltered for quality and
coverage and called across all mapped sites using SAMtools v0.1.12-10, with subsequent removal of
indels and masking of repetitive regions, mobile genetic elements, and recombination regions (5). This
approach resulted in a ﬁnal set of 1,076 concatenated SNVs in “clonal frame,” which was used (i) to
calculate pairwise core genome SNV differences between isolates and (ii) to generate maximum
likelihood phylogenies. Trees were produced using RAxML v8.1.23 (51) with a generalized time-reversible
(GTR) model of evolution and CAT approximation of rate heterogeneity and curated using FigTree v1.4.2
(52) and iToL v4 (53).
Comparative genomic analysis. Sequence reads were interrogated for MLST and acquired AMR
genes using the pubMLST and ARG-ANNOT databases, respectively, compiled within SRST2 v0.1.8 (54).
Genome assembly and annotation and comparative analysis of transposons (Tns), prophages, and
virulence loci were performed in silico as previously described (5). Annotated genomes were used as
input for pan-genome analysis with Roary v3.6.0 and PanGP v1.0.1 as previously described (5). Deﬁnitions
of the core and pan-genome and estimates of the irrespective size and trajectory were made using
models and regression algorithms proposed by Tettelin and colleagues (55), as previously described (5).
Antimicrobial susceptibility testing. MICs for 13 antimicrobials were determined using the CLSI
agar dilution methodology (56). Clinical breakpoints were applied as recommended by CLSI (for
amoxicillin/clavulanate, ceftriaxone, clindamycin, clindamycin, erythromycin, meropenem, moxiﬂoxacin,
piperacillin-tazobactam, and tetracycline), EUCAST (for vancomycin and metronidazole), and the Euro-
pean Medical Agency (for ﬁdaxomicin) as previously described (5). A MIC of 32 mg/liter was used to
deﬁne resistance to rifaximin (5), and there are no published breakpoints for trimethoprim.
Statistical analysis.Where appropriate, statistical signiﬁcance was determined using a 	2 test, t test,
or Kruskal-Wallis H test, using a cutoff P value of 0.05.
Data availability. All supplemental data for this article (Data Set S1) and 207 annotated C. difﬁcile
genome assemblies are hosted at the online digital repository ﬁgshare, available at https://doi.org/10
.6084/m9.ﬁgshare.4822255.
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